P060011S029

None

FDA Premarket Approval P060011 S029

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP060011S029
Classification NameNone
Applicant
PMAP060011
SupplementS029

Supplemental Filings

Supplement NumberDateSupplement Type
P060011Original Filing
S030 2022-07-21 30-day Notice
S029
S028 2021-07-06 30-day Notice
S027 2021-06-01 30-day Notice
S026 2021-02-01 Real-time Process
S025 2020-08-14 Normal 180 Day Track
S024 2020-05-26 30-day Notice
S023
S022 2020-05-11 30-day Notice
S021 2020-04-27 30-day Notice
S020 2020-03-02 30-day Notice
S019 2020-01-27 30-day Notice
S018 2019-07-01 30-day Notice
S017 2019-03-20 30-day Notice
S016 2019-03-01 30-day Notice
S015
S014 2018-04-02 Normal 180 Day Track
S013 2017-11-13 30-day Notice
S012 2017-07-03 Normal 180 Day Track No User Fee
S011 2017-04-21 30-day Notice
S010 2016-08-01 30-day Notice
S009 2016-05-09 30-day Notice
S008 2015-08-13 30-day Notice
S007 2015-06-05 135 Review Track For 30-day Notice
S006 2015-03-13 30-day Notice
S005 2015-02-02 Real-time Process
S004 2012-05-29 Real-time Process
S003 2012-02-06 30-day Notice
S002 2011-09-13 Real-time Process
S001 2011-02-28 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.